Home » Stocks » Core Laboratories

Core Laboratories N.V. (CLB)

Stock Price: $24.83 USD 0.31 (1.26%)
Updated Aug 11, 2020 2:19 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 1.10B
Revenue (ttm) 598.11M
Net Income (ttm) -80.08M
Shares Out 44.48M
EPS (ttm) -1.80
PE Ratio n/a
Forward PE 32.68
Dividend $0.04
Dividend Yield 0.16%

Stock Quote

Trading Day Aug 11, 2020
Last Price $24.83
Previous Close $24.52
Change ($) 0.31
Change (%) 1.26%
Day's Open 24.92
Day's Range 24.40 - 25.56
Day's Volume 336,896
52-Week Range 6.68 - 52.13

More Stats

Market Cap 1.10B
Enterprise Value 1.44B
Earnings Date (est) Oct 21, 2020
Ex-Dividend Date Jul 24, 2020
Shares Outstanding 44.48M
Float 43.66M
EPS (basic) -1.8
EPS (diluted) -1.80
FCF / Share 1.80
Dividend $0.04
Dividend Yield 0.16%
Earnings Yield n/a
FCF Yield 7.26%
Payout Ratio n/a
Shares Short 5.14M
Short Ratio 3.61
Short % of Float 13.09%
Beta 3.02
PE Ratio n/a
Forward PE 32.68
P/FCF Ratio 13.77
PS Ratio 1.85
PB Ratio 17.09
Revenue 598.11M
Operating Income -59.28M
Net Income -80.08M
Free Cash Flow 80.19M
Net Cash -335.13M
Net Cash / Share -7.53
Gross Margin 28.86%
Operating Margin -9.91%
Profit Margin -13.40%
FCF Margin 13.41%
ROA 6.30%
ROE -61.49%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (17)

Buy 3
Overweight 1
Hold 10
Underweight 1
Sell 2

Analyst Consensus: Overweight

Price Target

$20.63*
(-16.92% downside)
Low
14.0
Current: $24.83
High
27.0
Target: 20.63
*Average 12-month price target from 15 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue6687016485907981,0851,074981908795
Revenue Growth-4.66%8.19%9.76%-25.99%-26.51%1.09%9.42%8.09%14.22%-
Gross Profit173204183153265420411359314281
Operating Income96.6811911087.45161347333297251227
Net Income10279.5383.1363.90115257243216185145
Shares Outstanding44.3644.2144.1543.4842.7544.3645.6947.2146.2944.83
Earnings Per Share2.281.791.881.462.685.775.284.543.823.00
EPS Growth27.37%-4.79%28.77%-45.52%-53.55%9.28%16.3%18.85%27.33%-
Dividend Per Share2.202.202.202.202.202.001.281.121.000.89
Dividend Growth0%0%0%0%10%56.25%14.29%12%12.36%-
Operating Cash Flow89.53112124132219303298237204206
Capital Expenditures-21.56-22.05-18.45-10.96-22.94-36.56-37.91-32.13-29.25-27.13
Free Cash Flow67.9789.78106121196267260205175179
Cash & Equivalents11.0913.1214.4014.7622.4923.3525.0919.2329.33134
Total Debt382290227216431354267234223148
Net Cash / Debt-371-277-213-202-408-330-242-215-194-13.66
Assets775649585573625673661637611650
Liabilities593488436418649579492449429358
Book Value178157145151-29.0687.57163182178289
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Core Laboratories N.V.
Country Netherlands
Employees 3,800
CEO Lawrence V. Bruno

Stock Information

Ticker Symbol CLB
Stock Exchange New York Stock Exchange
Sector Basic Materials
Industry Oil & Gas Equipment & Services
Unique Identifier NYSE: CLB
IPO Date September 20, 1995

Description

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.